V B Grinevich

Kirov Military Medical Academy.

45 publications 1977 – 2022 ORCID

What does V B Grinevich research?

V B Grinevich studies the condition known as ulcerative colitis, which is an inflammatory bowel disease that causes long-lasting inflammation and ulcers in the digestive tract. His research primarily investigates new treatment methods to help patients manage their symptoms more effectively. One significant focus of his work is on propionyl-L-carnitine, a compound that seems to enhance treatment outcomes for patients who are already on stable oral medication for ulcerative colitis. He aims to provide alternative solutions that may lead to better symptom management and overall health.

Key findings

  • In a clinical trial, 72% of patients taking propionyl-L-carnitine reported a positive response to treatment compared to 50% in the placebo group.
  • The treatment was generally safe, with the majority of side effects being related to the stomach.
  • Patients receiving propionyl-L-carnitine showed a noticeable improvement in symptoms of ulcerative colitis.

Frequently asked questions

Does Dr. Grinevich study ulcerative colitis?
Yes, Dr. Grinevich focuses specifically on ulcerative colitis and seeks to develop better treatment options for patients.
What treatments has Dr. Grinevich researched?
Dr. Grinevich has researched propionyl-L-carnitine as a treatment for patients with ulcerative colitis who are already on stable medication.
Are Dr. Grinevich's findings relevant to my ulcerative colitis?
Yes, his findings regarding propionyl-L-carnitine could provide additional therapy options for managing your ulcerative colitis symptoms.

Publications in plain English

[Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians].

2022

Terapevticheskii arkhiv

Simanenkov VI, Maev IV, Tkacheva ON, Alekseenko SA, Andreev D +25 more

Plain English
This paper reviews guidelines for doctors on how to protect the gut lining in patients with related diseases. The experts identified 28 practical recommendations, focusing on treatments like proton pump inhibitors, bismuth drugs, and probiotics, showing that rebamipide is a key medication for protecting the gut. This matters because improving gut health can lead to better overall health for patients with multiple health issues. Who this helps: Patients with gastrointestinal conditions and their doctors.

PubMed

Effect of Prebiotic Complex on Gut Microbiota and Endotoxemia in Female Rats with Modeled Heart Failure.

2020

Bulletin of experimental biology and medicine

Vlasov AA, Shperling MI, Terkin DA, Bystrova OV, Osipov GA +2 more

Plain English
This study looked at the impact of a prebiotic supplement on gut health in female rats with heart failure. Researchers found that the levels of harmful bacteria and toxins in the blood were higher in the rats with heart failure, but these levels dropped significantly after they were treated with the prebiotic complex. This is important because it shows that the prebiotic can help improve gut health and reduce toxin levels in heart failure, suggesting it could be a useful treatment option. Who this helps: Patients with heart failure.

PubMed

[Gut microbiota and systemic inflammation in patients with chronic heart failure].

2020

Kardiologiia

Vlasov AA, Salikova SP, Grinevich VB, Bystrova OV, Osipov GA +1 more

Plain English
This study looked at the connection between chronic inflammation and gut bacteria in patients with chronic heart failure (CHF). Researchers found that patients with more severe symptoms of CHF had higher inflammation levels, as indicated by C-reactive protein levels and specific markers like NT-proBNP. Notably, patients with CHF had fewer beneficial gut bacteria and higher levels of harmful ones, which could be linked to their worsening condition. Who this helps: This helps patients with chronic heart failure and their doctors by highlighting the potential role of gut health in managing their condition.

PubMed

Russian consensus on exo- and endocrine pancreatic insufficiency after surgical treatment.

2018

Terapevticheskii arkhiv

Khatkov IE, Maev IV, Abdulkhakov SR, Alekseenko SA, Alikhanov RB +30 more

Plain English
This research focused on understanding how to diagnose and treat issues with the pancreas after surgery, specifically when it fails to produce important hormones and enzymes. Experts came together to agree on best practices, emphasizing the importance of teamwork between gastroenterologists and surgeons. These guidelines help ensure better patient care and management following pancreatic surgery. Who this helps: Patients recovering from pancreatic surgery.

PubMed

[The Russian consensus on the diagnosis and treatment of chronic pancreatitis: Enzyme replacement therapy].

2017

Terapevticheskii arkhiv

Khatkov IE, Maev IV, Bordin DS, Kucheryavyi YA, Abdulkhakov SR +42 more

Plain English
This research focused on how doctors in Russia diagnose and treat chronic pancreatitis, particularly emphasizing enzyme replacement therapy, which helps patients whose bodies do not produce enough digestive enzymes. The study brought together experts from various medical fields to unify their approaches and share best practices, which is vital since nearly 80% of patients with chronic pancreatitis experience poor digestion that can severely impact their quality of life. This standardization matters because it can lead to more consistent and effective patient care across the country. Who this helps: Patients suffering from chronic pancreatitis and their healthcare providers.

PubMed

Human gut microbiota community structures in urban and rural populations in Russia.

2013

Nature communications

Tyakht AV, Kostryukova ES, Popenko AS, Belenikin MS, Pavlenko AV +26 more

Plain English
This study examined the gut bacteria of 96 healthy adults in Russia from both urban and rural areas to understand how their microbiomes differ. Researchers found that rural populations have unique gut bacteria communities that are healthier, predominantly featuring two major groups of bacteria, Bacteroidetes and Firmicutes. These differences are likely influenced by the diet, culture, and socioeconomic status of people in these regions, highlighting the importance of these factors in gut health. Who this helps: This helps healthcare providers and researchers understand how environment and lifestyle affect gut health in different populations.

PubMed

[Standards for diagnosis and treatment of acid and Helicobacter pylori-associated diseases].

2013

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology

Lazebnik LB, Tkachenko EI, Abdulkhakov RA, Bordin DS, Grinevich VB +13 more

PubMed

[Chronic pancreatitis: microbe-intestinal tissue complex and systemic inflammatory response].

2011

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology

Grinevich VB, Sas EI, Denisov NL, Efimov OI

Plain English
This study focused on patients with chronic pancreatitis, a condition that is becoming more common in Russia but is difficult to treat effectively. Researchers found that a combination of therapies, including medication to reduce stomach acid, relieve spasms, and support gut health with prebiotics, significantly decreased inflammation and improved treatment outcomes. Specifically, adding prebiotics helped balance gut bacteria and reduced overall inflammation in these patients. Who this helps: This helps patients with chronic pancreatitis by providing a more effective treatment approach.

PubMed

Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment.

2011

Alimentary pharmacology & therapeutics

Mikhailova TL, Sishkova E, Poniewierka E, Zhidkov KP, Bakulin IG +15 more

Plain English
In this study, researchers looked at the effects of propionyl-L-carnitine (PLC) on patients with mild-to-moderate ulcerative colitis (UC) who were already stable on treatment. They found that 72% of patients taking PLC had a positive response to treatment, compared to 50% in the placebo group, showing that PLC may help improve symptoms. The treatment was generally safe, with side effects mostly related to the stomach. Who this helps: This helps patients with ulcerative colitis looking for better management options.

PubMed

[VIII Congress of Russian Gastroenterological Scientific Society. XXXIV Session of the Central Research Institute of Gastroenterology (4-7 March, 2008, Moscow). Standards "Diagnosis and therapy of acid-dependent diseases including Helicobacter pylori-associated diseases" (Third Moscow Agreement, 04.02.05 with supplements adopted on 06.03.08 by VIII Congress of Russian Gastroenterological Scientific Society)].

2008

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology

, Bredikhina NA, Butov MA, Vasil'ev IuV, Golovanova ES +22 more

PubMed

[Clinical efficacy of probiotics in complex treatment of called-up servicemen with community-acquired pneumonia].

2006

Voenno-meditsinskii zhurnal

Rakov AL, Grinevich VB, Kriukov AE, Bogdanov IV, Rysev AV +3 more

PubMed

[Clinical efficacy of neosmektin as a part of complex therapy of patients with chronic pancreatitis].

2006

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology

Grinevich VB, Sas EI

PubMed

[Eradication therapy of Helicobacter pylori--associated diseases: efficacy, safety, pharmacoeconomy].

2005

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology

Grinevich VB, Sablin OA, Gubonina IV, Dobrenko VA

PubMed

[New approaches to correction of the nutritional status in servicemen with body mass deficiency].

2004

Voenno-meditsinskii zhurnal

Grinevich VB, Rakov AL, Uspenskiĭ IuP, Bogdanov IV, Kutuev KhA +3 more

PubMed

[Device laboratory and postmortem parallels in alcoholic hepatitis during combined therapy using thioctic (alpha-lipoic) acid].

2004

Klinicheskaia meditsina

Kravchuk IuA, Mekhtiev SN, Uspenskiĭ IuP, Grinevich VB, Koblov SV

Plain English
This study looked at how well a treatment called thioctic acid (also known as alpha-lipoic acid) works in patients with alcoholic hepatitis, focusing on 61 individuals with an average age of about 42. The researchers found that using this treatment helped reduce liver damage and inflammation, which was shown by improved liver enzyme levels and changes in the liver’s structure. This finding is important because it highlights a potential way to better treat and manage alcoholic hepatitis, helping to prevent further liver damage. Who this helps: This helps patients suffering from alcoholic hepatitis.

PubMed

[Clinical and pharmacoeconomic substantiation of the modification of eradication therapy regimens for Helicobacter pylori-associated diseases].

2004

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology

Grinevich VB, Samedov BKh, Uspenskiĭ IuP, Gubonina IV

PubMed

[New prospects in treating chronic pancreatitis (clinico-pharmacoeconomic study)].

2003

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology

Grinevich VB, Ivanikov IO, Uspenskiĭ IuP, Lasyĭ VP, Shcherbina NN +1 more

Plain English
This research looked at different surgical methods for treating inguinal hernias, a common condition where tissue bulges through a weak spot in the groin. Findings showed that no single surgery completely prevents hernias from coming back, but a careful choice of technique—based on the surgeon's experience and the materials used—can lead to better outcomes. This matters because it highlights the importance of personalized treatment plans to improve recovery for patients. Who this helps: Patients undergoing surgery for inguinal hernias.

PubMed

[Project. Therapy of acid-dependent diseases. First Moscow Agreement, February 5, 2003].

2003

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology

Lazebnik LB, Vasil'ev IuV, Prigor'ev PIa, Grinevich VB, Malferntheiner P +5 more

PubMed

[Problems in the diagnosis of dysbacteriosis under the influence of environmental factors].

2003

Gigiena i sanitariia

Zakharchenko MP, Grinevich VB, Dobrynin VM, Zakharchenko MM, Dobrynina IA +1 more

PubMed

[Secretolytic therapy of acid-dependent diseases of the digestive system from the point of view of a clinician].

2003

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology

Grinevich VB, Uspenskiĭ IuP

PubMed

[Characteristics of non-Helicobacter pylori ulcer disease].

2002

Terapevticheskii arkhiv

Grinevich VB, Uspenskiĭ IuP, Shabanova GZh, Shcherbina NN

Plain English
This study looked at ulcer disease in patients to understand how it differs for those infected with Helicobacter pylori (HP) compared to those who are not. Among 411 patients, 338 were found to have HP, while the remaining had unique psychological and physical symptoms. Adding mental health medications to standard ulcer treatments helped these patients recover faster and improved their quality of life. Who this helps: This benefits patients with non-HP related ulcers.

PubMed

[Pharmacotherapy of non-associated with Helicobacter pylori ulcer].

2002

Klinicheskaia meditsina

Grinevich VB, Uspenskiĭ IuP, Shabanova GZh, Sablin OA, Shcherbina NN

Plain English
This study looked at 77 patients with ulcers that were not caused by a bacteria called Helicobacter pylori. The researchers found that treating these patients with famotidine, followed by either phosphalugel for duodenal ulcers or de-nol for gastric ulcers, was more effective than using ranitidine. This treatment helped patients stay ulcer-free and had fewer side effects. Who this helps: This benefits patients suffering from ulcers that aren't linked to Helicobacter pylori.

PubMed

[Acid-base blood balance in patients with ulcer under treatment by the gastric secretion inhibitors and antacids].

2002

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology

Grinevich VB, Sablin OA, Uspenskiĭ IuL

Plain English
Researchers studied 25 patients with duodenal ulcers to see how different medications affected their stomach acidity and the acid-base balance in their blood. After two weeks of treatment with drugs like omeprazole or famotidine, significant changes were observed; for example, the majority of patients showed improved acid-base balance. This is important because managing acidity can lead to better healing of ulcers and overall health. Who this helps: This helps patients with duodenal ulcers and their doctors in choosing effective treatments.

PubMed

[Classification of erosive alterations of gastric and duodenal mucosa].

1996

Klinicheskaia meditsina

Grinevich VB, Tkachenko EI, Uspenskiĭ

PubMed

[Acute and chronic gastroduodenal erosions: characteristics of etiology, pathogenesis, clinical aspects and diagnosis].

1994

Klinicheskaia meditsina

Grinevich VB, Uspenskiĭ IuP, Vologzhanin DA, Grigor'ev EP, Kalinin AV

Plain English
This study looked at 2,620 patients with various health issues and found that 252 had acute stomach and gut erosions, while 178 had chronic ones. The researchers discovered that chronic erosions were often linked to problems with blood circulation and liver function, affecting about 75% of those cases. Understanding these connections is important for doctors to better diagnose and treat these conditions. Who this helps: This helps patients with stomach and gut issues and their doctors.

PubMed

[Dyspepsia of a nonulcerous nature in servicemen under conditions of ecological-occupational stress].

1994

Voenno-meditsinskii zhurnal

Grinevich VB, Uspenskiĭ IuP, Melkumov SP

Plain English
This study looked at servicemen who had non-ulcer dyspepsia, a digestive issue that causes discomfort without the presence of ulcers, often caused by stressful work environments. Researchers found that these servicemen suffered from changes in the lining of the stomach and small intestine, indicating underlying damage, while some had problems with how their stomach and intestines move food along. This matters because understanding these symptoms can lead to better care and treatment for affected servicemen. Who this helps: This helps servicemen with digestive issues related to their stressful work conditions.

PubMed

[The course of the reparative process in patients with gastric and duodenal peptic ulcers (a clinico-statistical study)].

1993

Terapevticheskii arkhiv

Grinevich VB, Tkachenko EI, Uspenskiĭ IuP

Plain English
This study looked at the healing process in 332 patients with stomach ulcers and 294 patients with duodenal ulcers. Researchers found that the size and location of the ulcer, along with factors like stomach acid levels and smoking habits, significantly impacted how well the ulcers healed. These findings are important because they can help doctors tailor treatments to improve recovery for patients with these types of ulcers. Who this helps: This helps patients with gastric and duodenal ulcers, as well as their doctors.

PubMed

[Quantitative and qualitative changes in blood leukocytes in patients with duodenal ulcer and their diagnostic significance].

1992

Klinicheskaia meditsina

Tkachenko EI, Grinevich VB, Vologzhanin DA

PubMed

[The dynamic functional-morphological changes in the small intestine of obese patients undergoing weight-reducing diet therapy].

1992

Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova

Tkachenko EI, Luft VM, Grukhin IuA, Grinevich VB, Pershko AM

Plain English
This study looked at 28 obese patients undergoing a weight-loss diet and found that their small intestine showed two main types of changes during fasting: one involved structural changes in the lining of the intestine that reduced cell growth, and the other involved inflammation with increased immune cell presence. By the 26th day of following the diet, their intestinal lining had fully recovered. This is important because it shows that a diet can restore gut health in obese patients. Who this helps: Patients who are obese and seeking to improve their gut health through diet.

PubMed

[Gastric and duodenal peptic ulcer in combination with erosions].

1991

Vrachebnoe delo

Tkachenko EI, Grinevich VB, Uspenskiĭ IuP, Vologzhanin DA, Grigor'ev EP

PubMed

[The specificity of the peripheral blood changes in patients with gastric peptic ulcer].

1991

Vrachebnoe delo

Tkachenko EI, Ivashkin VT, Grinevich VB, Kovalenko VI, Vologzhanin DA

Plain English
This study looked at the white blood cells (leucocytes) in 112 patients with stomach ulcers to see how their levels changed over time. Researchers found that the number and type of white blood cells in the blood changed in phases as the ulcer healed. This matters because understanding these changes can help doctors better monitor and treat patients with stomach ulcers. Who this helps: This helps doctors and patients with gastric ulcers.

PubMed

[Erosive changes of the gastroduodenal mucosa--is it a pre-ulcer state?].

1991

Klinicheskaia meditsina

Grinevich VB, UspenskiI IuP, Grigor'ev EP, Kalinin AV

Plain English
This study looked at 280 patients with ulcers and found that 107 of them had erosive gastritis, duodenitis, or gastroduodenitis, which are early signs that could lead to ulcers. The researchers found that the type and location of these erosions, as well as the body's response to them and how it processes nutrients, play a role in developing ulcers. Understanding these early changes is important because it could help prevent ulcers from forming in the first place. Who this helps: Patients at risk of developing ulcers.

PubMed

[A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer].

1989

Terapevticheskii arkhiv

Ivashkin VT, Tkachenko EI, Grinevich VB, Sultanov VK, Inozemtsev SA

Plain English
This study looked at how effective different treatments were for peptic ulcers, comparing sucralfate to other medications like cimetidine, ranitidine, and antacids. The results showed that sucralfate completely healed ulcers in all patients after 5 weeks, while ranitidine healed 90%, cimetidine healed 84%, and antacids and cholinolytics healed 78%. This matters because it highlights sucralfate as a highly effective option for treating ulcers, potentially leading to better care for patients. Who this helps: Patients suffering from peptic ulcers.

PubMed

[Mechanisms of the chronicity of peptic ulcer].

1988

Terapevticheskii arkhiv

Dorofeev GI, Uspenskiĭ VM, Luft VM, Grinevich VB, Zelenyĭ VA

PubMed

[Experience using the color television camera for endoscopic studies in gastroenterology].

1987

Klinicheskaia meditsina

Dorofeev GI, Bass RM, Vasil'ev IV, Vishnevskiĭ TI, Grinevich VB

PubMed

[Functional and morphological status of the gastric mucosa mast cells on the administration of dimedrol and suprastin].

1983

Farmakologiia i toksikologiia

Uspenskiĭ VM, Zelenyĭ VA, Grinevich VB, Fokina AA

Plain English
This study looked at how two antihistamines, dimedrol and suprastin, affect mast cells in the stomach and small intestine of rats over 45 days. The researchers found that these medications boosted the activity of mast cells, leading to more new mast cells forming and older ones breaking down faster. This is important because it helps us understand how antihistamines might influence stomach health and immune response. Who this helps: This helps patients with stomach issues who may benefit from antihistamine treatment.

PubMed

[Gastric mucosal mast cells and precancerous states].

1981

Voprosy onkologii

Uspenskiĭ VM, Grinevich VB

Plain English
This study examined the presence of mast cells in the stomach lining of 30 gastric cancer patients and 190 patients with precancerous conditions. The researchers found that in patients with chronic atrophic gastritis and persistent ulcers, the number of mast cells was significantly reduced, which also occurred in the gastric cancer patients. This finding is important because it suggests that changes in mast cells could serve as early warning signs of stomach cancer. Who this helps: This helps patients at risk for stomach cancer and their doctors in identifying precancerous changes early.

PubMed

[Effect of prolonged administration of prednisolone on the functional and morphological state of mast cells in the gastric and duodenal mucosa].

1981

Farmakologiia i toksikologiia

Uspenskiĭ VM, Grinevich VB, Fokina AA

PubMed

[Role of gastroduodenal reflux in the formation of gastroduodenal pathology].

1980

Terapevticheskii arkhiv

Uspenskiĭ VM, Grinevich VB

PubMed

[Mast cells as a criterion of repair process activity in ulcerative stomach lesions].

1980

Arkhiv patologii

Uspenskiĭ VM, Grinevich VB

Plain English
This study looked at mast cells in patients with stomach ulcers and cancer to see how they relate to healing. It involved 215 patients with peptic ulcers and 23 with gastric cancer. The researchers found that more mast cells were present around healing ulcers, while those in chronic ulcers or cancer showed fewer mast cells, which helps in diagnosing and understanding these conditions. Who this helps: This helps patients with stomach ulcers and doctors treating them.

PubMed

[Mast cells as a cellular mechanism for the trophic effects of the autonomic nervous system on the gastroduodenal mucosa].

1980

Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova

Uspenskiĭ VM, Grinevich VB, Fokina AA

PubMed

[Trophic role of mast cells in the gastric mucosa during secretory process].

1979

Terapevticheskii arkhiv

Uspenskiĭ VM, Grinevich VB

PubMed

[Histochemical characteristics of the gastric and duodenal mucosa of rabbits shielded from the earth's magnetic field during their development].

1978

Kosmicheskaia biologiia i aviakosmicheskaia meditsina

Efimenko GD, Shakula AV, Uspenskiĭ VM, Grinevich VB, Galeev ISh

PubMed

[Participation of mast cells of the gastric mucosa in secretory process].

1977

Vrachebnoe delo

Uspenskiĭ VM, Grinevich VB

PubMed

[Trophic effect of pentagastrin on the gastric and duodenal mucosa].

1977

Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova

Uspenskiĭ VM, Grinevich VB, Fokina AA

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.